Skip to main content
Skip to content
Case File
efta-efta01521620DOJ Data Set 10Correspondence

EFTA Document EFTA01521620

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01521620
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL ACCT. For the Period 4/1/13 to 413W13 Equity Summary Asset Categories US Large Cap Equity 43.128.61 43.754.11 625.50 1% US Small/Mid Cap Equity 3,210.00 3,510.00 300.00 1% Non-US Equity 140.53 136.29 (4.24) 1% Preferred Stocks 457,935.00 455,201.00 (2,734.00) 4% Concentrated 8 Other Equity 218,835.00 224726.00 3,891.00 2% Total Value 5721,249.14 5723,327.40 $2,078.26 9% Beginning Ending Change Current Asset Categories Market Value Market Value In Value Allocation Market Value/Cost Current Period Value Market Value 723.327.40 Tax Cost 693.954.39 Unrealized Gain/Loss 29.373.01 Estimated Annual Income 45.721 83 Accrued Dividends 1,858.50 Yield 6.29% Equity Detail Non-US Equity US SmaqUid Cep Equity US Larpe Cup &poly Equity as a percentage of your portfolio - 9 % Preferred Stocks Conteutrated it Other Equity Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gaintoss Accrued Div. Yield US Large Cap Equity APACHE CORP 037411-10-5 APA 73.88 95.000 7,018.60 11,403.30 (4.384.70) 76.00 1.08% 19.00 JP Morgan Page 5 of 32 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00049026 SDNY_GM_00318224 EFTA01521620

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.